Methadone in Pediatric Anesthesia
Information source: Washington University School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anesthesia
Intervention: Methadone (Drug)
Phase: N/A
Status: Completed
Sponsored by: Washington University School of Medicine Official(s) and/or principal investigator(s): Evan Kharasch, MD, PhD, Principal Investigator, Affiliation: Washington University School of Medicine
Summary
This study will determine the pharmacokinetics of intravenous (IV) methadone in children
undergoing surgery.
Clinical Details
Official title: Methadone in Pediatric Anesthesia
Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Determine PKs of IV methadone in children undergoing surgery
Eligibility
Minimum age: 5 Years.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age 5-18
- Undergoing General anesthesia and surgery with anticipated postoperative inpatient
stay of greater than or equal to 3 days
- Signed, written, informed consent from legal guardians and assent from patient
Exclusion Criteria:
- History of or known liver or kidney disease
Locations and Contacts
Washington University School of Medicine, St. Louis, Missouri 63110, United States
Additional Information
Starting date: May 2009
Last updated: June 2, 2015
|